68Ga-pentixafor PET/CT 靶向 CXCR4 在非霍奇金淋巴瘤中的初步成像证据:与 18F-FDG 比较
结果示 CXCR4 表达在不同类型淋巴瘤中各异,淋巴浆细胞淋巴瘤和边缘区淋巴瘤中 68Ga-pentixafor 摄取高于 18F-FDG 且病变范围更广;外周 T 细胞淋巴瘤非特指型和 NK/T 细胞淋巴瘤未见摄取。
要点
- 68Ga-pentixafor PET 在淋巴浆细胞淋巴瘤、边缘区淋巴瘤、弥漫大 B 细胞淋巴瘤、滤泡性淋巴瘤、套细胞淋巴瘤、未分类惰性 B 细胞淋巴瘤和肠病相关 T 细胞淋巴瘤中显示摄取增高。
- 外周 T 细胞淋巴瘤非特指型和 NK/T 细胞淋巴瘤对 68Ga-pentixafor 无摄取。
- 淋巴浆细胞淋巴瘤和边缘区淋巴瘤中,68Ga-pentixafor 较 18F-FDG 显示更广泛病变和更高放射性摄取。
核心结论
- CXCR4 表达在不同类型非霍奇金淋巴瘤中各异,68Ga-pentixafor PET/CT 可检测其过表达。
- 淋巴浆细胞淋巴瘤和边缘区淋巴瘤中 68Ga-pentixafor 摄取高于 18F-FDG。
主要发现
- 68Ga-pentixafor PET 在淋巴浆细胞淋巴瘤(n=8)、边缘区淋巴瘤(n=4)、弥漫大 B 细胞淋巴瘤(n=3)、滤泡性淋巴瘤(n=2)、套细胞淋巴瘤(n=1)、未分类惰性 B 细胞淋巴瘤(n=3)和肠病相关 T 细胞淋巴瘤(n=3)中显示放射性摄取增高。
- 外周 T 细胞淋巴瘤非特指型(n=1)和 NK/T 细胞淋巴瘤(n=2)对 68Ga-pentixafor 无摄取。
- 与 18F-FDG PET 比较,68Ga-pentixafor PET 在淋巴浆细胞淋巴瘤和边缘区淋巴瘤中显示更广泛病变和更高放射性摄取。
临床怎么用
- 对于淋巴浆细胞淋巴瘤和边缘区淋巴瘤,68Ga-pentixafor PET/CT 可能较 18F-FDG 提供更全面的病变范围和更高摄取信息。
- 外周 T 细胞淋巴瘤非特指型和 NK/T 细胞淋巴瘤患者不宜依赖 68Ga-pentixafor PET/CT 评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In order to study the CXCR4 expression with [68Ga]pentixafor PET in different types of non-Hodgkin lymphoma, we performed a retrospective study to describe the [68Ga]pentixafor PET/CT imaging in a spectrum of lymphomas and to compare it with [18F]FDG PET/CT. RESULTS: Twenty-seven patients with newly diagnosed non-Hodgkin lymphoma were recruited retrospectively. [68Ga]pentixafor PET showed increased radioactivity in lymphoplasmacytic lymphoma (n = 8), marginal zone lymphoma (n = 4), diffuse large B cell lymphoma (n = 3), follicular lymphoma (n = 2), mantle cell lymphoma (n = 1), unclassified indolent B cell lymphoma (n = 3), and enteropathy associated T cell lymphoma (n = 3). However, peripheral T cell lymphoma, not otherwise specified (n = 1), and NK/T cell lymphoma (n = 2) were not avid for [68Ga]pentixafor. In comparison to [18F]FDG PET, [68Ga]pentixafor PET demonstrated more extensive disease and higher radioactivity in lymphoplasmacytic lymphoma and marginal zone lymphoma. CONCLUSION: CXCR4 expression varies in different types of non-Hodgkin lymphoma. Overexpression of CXCR4 was detected with [68Ga]pentixafor PET/CT in lymphoplasmacytic lymphoma, marginal zone lymphoma, diffuse large B cell lymphoma, follicular lymphoma, mantle cell lymphoma, unclassified indolent B cell lymphoma, and enteropathy associated T cell lymphoma. The uptake of [68Ga]pentixafor was higher than [18F]FDG in lymphoplasmacytic lymphoma and marginal zone lymphoma.
引用
- Pan Q, Luo Y, Zhang Y, et al. Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [68Ga]pentixafor in non-Hodgkin lymphoma: comparison to [18F]FDG. EJNMMI Res. 2020. PMID: 32757068. doi:10.1186/s13550-020-00681-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。